NRC Health(NRC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 6:52 PM ET (Korea 10/30 07:52)
Full metrics table
| Index | RUT | P/E | 84.53 | EPS (ttm) | 0.28 | Insider Own | 44.16% | Shs Outstand | 21.2M | Perf Week | 9.87% |
| Market Cap | 0.52B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 12.3M | Perf Month | 10.85% |
| Enterprise Value | 0.62B | PEG | - | EPS next Q | 0.24 | Inst Own | 49.59% | Short Float | 5.88% | Perf Quarter | 20.4% |
| Income | 0.01B | P/S | 3.61 | EPS this Y | - | Inst Trans | -2.18% | Short Ratio | 6.12 | Perf Half Y | 42.71% |
| Sales | 0.14B | P/B | - | EPS next 5Y | -8.11% | ROA | 4.49% | Short Interest | 0.73M | Perf YTD | 25.15% |
| Book/sh | -0.43 | P/C | 143.14 | EPS past 3/5Y | -26.48% -19.02% | ROE | 237.67% | 52W High | -1.43% ($23.83) | Perf Year | 74.65% |
| Cash/sh | 0.16 | P/FCF | 28.16 | Sales past 3/5Y | -3.22% 0.61% | ROIC | 6.93% | 52W Low | 100.17% ($11.73) | Perf 3Y | -44.16% |
| Dividend Est. | $0.64 (2.72%) | EV/EBITDA | 25.35 | EPS Y/Y TTM | -59.53% | Gross Margin | 54.78% | Volatility(W/M) | 5.99% 4.33% | Perf 5Y | -44.55% |
| Dividend TTM | 0.64 | EV/Sales | 4.3 | Sales Y/Y TTM | 3.37% | Oper. Margin | 11.07% | ATR (14) | 1.01 | Perf 10Y | 54.93% |
| Dividend Ex-Date | 2026/12/29 | Quick Ratio | 0.65 | EPS Q/Q | 16.34% | Profit Margin | 4.29% | RSI (14) | 65.11 | Recom | 1 |
| Dividend Gr. 3/5Y | -14.77% 19.88% | Current Ratio | 0.64 | Sales Q/Q | 10.95% | SMA20 | 11.76% ($21.02) | Beta | 0.27 | Target Price | $27 |
| Payout | 103.13% | Debt/Eq | - | Earnings | 2026/10/27 | SMA50 | 10.92% ($21.18) | Rel Volume | 1.05 | Prev Close | $23.47 |
| Employees | 357 | LT Debt/Eq | - | EPS/Sales Surpr. | 16.67% 7.26% | SMA200 | 22.61% ($19.16) | Avg Volume(3M) | 0.12M | Price | $23.49 |
| IPO | 2013/5/23 | Option/Short | Yes/Yes | Trades | 2376 | Volume | 124,686 | Change | 0.09% |
🏥 NRC Health is a U.S.-based healthcare information services company that measures and analyzes patient experience, reputation, and market insights for healthcare institutions. It provides subscription-based solutions that enable hospitals and health systems to collect patient feedback and apply it to operational improvements and reputation management, featuring a stable revenue structure built on recurring contracts.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded about as much as usual. That is 105% of its average volume.
NRC makes money but has a weak balance sheet
Of every $100 in sales, $11.07 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -8.1% this year.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $2,535. Peers typically go for $1,418. Compared with its own 5-year average, it is 227% pricier now.
Tap to view numbers
Not enough quarters to judge yet
Only 2 quarter(s) reported, so no grade yet.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -44.5%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are more than it earns
It pays out 103% of what it earns.
Tap to view numbers
Ownership looks stable
Institutions hold 49.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #20 of 41 in the industry
Based on market cap of $520M.
FAQ
What kind of company is NRC?
NRC belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of NRC?
The market cap of NRC is approximately $520M, ranking 3,126 within its sector.
Does NRC pay dividends?
NRC has a dividend yield of approximately 2.72%, with an annual dividend of $0.64.
What is the P/E ratio of NRC?
NRC has a P/E ratio of approximately 84.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NRC?
NRC has recorded a 52-week high of $23.83 and a low of $11.73.
